The concentration of AGEs in patients without diabetic nephropathy carriers of the GSTO1*AA genotype was 27.36 μg/mL compared to the concentration of 38.42 μg/mL in patients with diabetic nephropathy carriers of the same genotype. This evidence concerns the gene GSTO1 and diabetic kidney disease.